Tracy Adams

Tracy Adams supports the W40M MRC0 West agency within the Department of the Army by managing critical procurement activities that ensure operational medical readiness for deployed forces. Focused on acquiring advanced diagnostic, therapeutic, and laboratory support systems, Adams oversees contracts for in-vitro diagnostic substances, surgical instrumentation, sterilization equipment, and blood management solutions essential to high-acuity field care. Their work directly enables the agency’s mission of sustaining medical sovereignty through timely, reliable access to mission-critical healthcare technologies, ensuring that combat medics and forward surgical teams are equipped with the most effective, FDA-compliant tools available. Adams maintains consistent relationships with leading medical technology providers including Roche Diagnostics Corporation, Cardinal Health 414, LLC, and Surgical Neuromonitoring Associates, Inc., partnering with vendors who deliver precision-engineered, clinically validated solutions. These collaborations emphasize compliance with military specifications, supply chain resilience, and rapid deployment capabilities. KJ Trauma Consulting and Premier Shockwave, Inc. further extend the agency’s capacity to integrate trauma response innovations into field medical operations, reflecting a preference for contractors with proven expertise in military-relevant medical platforms. While the majority of acquisitions (85.7%) are conducted as unrestricted procurements, Adams maintains a meaningful commitment to small business participation, with 14.3% of awards structured as total small business set-asides under FAR 19.5. This reflects a balanced approach that prioritizes mission performance while fostering innovation from qualified small vendors. The agency’s procurement portfolio is heavily concentrated in NAICS 811210 for electronic and precision equipment repair and maintenance, underscoring a technical focus on sustaining complex diagnostic and monitoring systems. Additional emphasis is placed on in-vitro diagnostic substance manufacturing (325413), with secondary activity in hazardous and nonhazardous waste treatment services, indicating a comprehensive lifecycle approach to medical logistics and environmental compliance.